BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2019 10:38:02 AM | Browse: 729 | Download: 1075
 |
Received |
|
2019-02-06 03:58 |
|
Peer-Review Started |
|
2019-02-12 06:08 |
|
To Make the First Decision |
|
2019-06-05 06:23 |
|
Return for Revision |
|
2019-06-27 01:27 |
|
Revised |
|
2019-07-02 15:39 |
|
Second Decision |
|
2019-07-26 09:24 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-07-29 18:20 |
|
Articles in Press |
|
2019-07-29 18:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-09-06 06:19 |
|
Publish the Manuscript Online |
|
2019-09-12 10:38 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected byan in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Advancements and challenges in treating advanced gastric cancer in the West
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jennifer L Leiting and Travis E Grotz |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Travis E Grotz, MD, Assistant Professor, Surgical Oncologist, Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, 200 First St. Southwest, Rochester, MN 55905, United States. grotz.travis@mayo.edu |
| Key Words |
Gastric cancer; D2 lymphadenectomy; Minimally invasive surgery; Neoadjuvant chemotherapy; Chemoradiation; Targeted treatments |
| Core Tip |
The treatment of advanced gastric cancer in the West continues to evolve and advance. Surgery-related outcomes continue to improve and have included the addition of minimally invasive surgery techniques. The use of chemotherapy to improve long-term survival outcomes has been demonstrated in randomized-controlled trials, though the best regimen to use continues to be investigated. Chemoradiation has also been shown to improve outcomes, though the timing, sequence, and patient-population for optimal benefit has yet to be determined. Targeted-therapies and intraperitoneal chemotherapy may also play a role in the treatment of patients with advanced gastric cancer. |
| Publish Date |
2019-09-12 10:38 |
| Citation |
Leiting JL, Grotz TE. Advancements and challenges in treating advanced gastric cancer in the West. World J Gastrointest Oncol 2019; 11(9): 652-664 |
| URL |
https://www.wjgnet.com/1948-5204/full/v11/i9/652.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v11.i9.652 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
